Stephen Schmidt

1.4k total citations
16 papers, 347 citations indexed

About

Stephen Schmidt is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Organic Chemistry. According to data from OpenAlex, Stephen Schmidt has authored 16 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Organic Chemistry. Recurrent topics in Stephen Schmidt's work include Lung Cancer Treatments and Mutations (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Brain Metastases and Treatment (2 papers). Stephen Schmidt is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Brain Metastases and Treatment (2 papers). Stephen Schmidt collaborates with scholars based in United States, Germany and Italy. Stephen Schmidt's co-authors include Megha Subramanian, Franziska M. Ippen, Anita Giobbie‐Hurder, Priscilla K. Brastianos, Daniel P. Cahill, María Martínez-Lage, Scott L. Carter, Hiroaki Wakimoto, Benjamin M. Kuter and Gregory R. Wojtkiewicz and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Cancer Research.

In The Last Decade

Stephen Schmidt

15 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Schmidt United States 10 163 86 78 49 44 16 347
Christine Flefleh United States 9 111 0.7× 159 1.8× 64 0.8× 19 0.4× 18 0.4× 13 409
Sourik S. Ganguly United States 10 244 1.5× 142 1.7× 74 0.9× 25 0.5× 40 0.9× 15 403
François Béliveau Canada 12 179 1.1× 71 0.8× 19 0.2× 16 0.3× 20 0.5× 17 394
Joanna Stachura Poland 11 155 1.0× 99 1.2× 63 0.8× 13 0.3× 70 1.6× 21 417
Song Shan China 9 304 1.9× 188 2.2× 31 0.4× 38 0.8× 69 1.6× 25 451
Darla Landfair 5 241 1.5× 75 0.9× 34 0.4× 26 0.5× 34 0.8× 8 370
Anna Ma United States 5 254 1.6× 159 1.8× 35 0.4× 44 0.9× 79 1.8× 8 381
Yi Su China 12 374 2.3× 72 0.8× 72 0.9× 15 0.3× 17 0.4× 20 514
Colin Mooney United States 6 139 0.9× 188 2.2× 58 0.7× 50 1.0× 41 0.9× 9 461
Sijana H. Dzinic United States 11 311 1.9× 80 0.9× 48 0.6× 16 0.3× 17 0.4× 15 476

Countries citing papers authored by Stephen Schmidt

Since Specialization
Citations

This map shows the geographic impact of Stephen Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Schmidt more than expected).

Fields of papers citing papers by Stephen Schmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Schmidt. The network helps show where Stephen Schmidt may publish in the future.

Co-authorship network of co-authors of Stephen Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Schmidt. A scholar is included among the top collaborators of Stephen Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Schmidt. Stephen Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wang, Cuihua, David Cheng, Gregory R. Wojtkiewicz, et al.. (2021). Highly Efficient Activatable MRI Probe to Sense Myeloperoxidase Activity. Journal of Medicinal Chemistry. 64(9). 5874–5885. 19 indexed citations
2.
Vinegoni, Claudio, Paolo Fumene Feruglio, Gabriel Courties, et al.. (2020). Fluorescence microscopy tensor imaging representations for large-scale dataset analysis. Scientific Reports. 10(1). 5632–5632. 9 indexed citations
3.
Cremer, Sebastian, Maximilian J. Schloss, Claudio Vinegoni, et al.. (2020). Diminished Reactive Hematopoiesis and Cardiac Inflammation in a Mouse Model of Recurrent Myocardial Infarction. Journal of the American College of Cardiology. 75(8). 901–915. 25 indexed citations
4.
Ippen, Franziska M., Christopher Alvarez‐Breckenridge, Benjamin M. Kuter, et al.. (2019). The Dual PI3K/mTOR Pathway Inhibitor GDC-0084 Achieves Antitumor Activity in PIK3CA -Mutant Breast Cancer Brain Metastases. Clinical Cancer Research. 25(11). 3374–3383. 61 indexed citations
5.
Raigani, Siavash, Shannon N. Tessier, Gregory R. Wojtkiewicz, et al.. (2019). Ex vivo perfusion-based engraftment of genetically engineered cell sensors into transplantable organs. PLoS ONE. 14(12). e0225222–e0225222. 12 indexed citations
6.
Ippen, Franziska M., Julia Grosch, Megha Subramanian, et al.. (2019). Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases. Neuro-Oncology. 21(11). 1401–1411. 77 indexed citations
7.
Edgar, Kyle A., Emily J. Hanan, Steven T. Staben, et al.. (2017). Abstract 156: Preclinical characterization of GDC-0077, a specific PI3K alpha inhibitor in early clinical development. Cancer Research. 77(13_Supplement). 156–156. 11 indexed citations
8.
Song, K S, Stephen Schmidt, Rebecca Hong, et al.. (2017). Abstract S6-04: The PI3K inhibitor, taselisib, has enhanced potency in PIK3CA mutant models through a unique mechanism of action. Cancer Research. 77(4_Supplement). S6–4. 6 indexed citations
9.
Hanan, Emily J., Marian C. Bryan, Yuan Chen, et al.. (2015). 4-Aminoindazolyl-dihydrofuro[3,4-d]pyrimidines as non-covalent inhibitors of mutant epidermal growth factor receptor tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 26(2). 534–539. 39 indexed citations
10.
Lee, Wendy, Daniel F. Ortwine, Philippe Bergeron, et al.. (2013). A hit to lead discovery of novel N-methylated imidazolo-, pyrrolo-, and pyrazolo-pyrimidines as potent and selective mTOR inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(18). 5097–5104. 26 indexed citations
11.
Kotze, Maritha J., J. Nico P. de Villiers, Louise Warnich, et al.. (2006). Lack of clinical manifestation of hereditary haemochromatosis in South African patients with multiple sclerosis. Metabolic Brain Disease. 21(2-3). 105–116. 16 indexed citations
12.
Bembenek, Michael E., et al.. (2003). Characterization of the Kinase Domain of the Ephrin-B3 Receptor Tyrosine Kinase Using a Scintillation Proximity Assay. Assay and Drug Development Technologies. 1(4). 555–563. 3 indexed citations
13.
Rustgi, Anil K., Lin Xu, Denise Pinney, et al.. (1995). Neurofibromatosis 2 gene in human colorectal cancer. Cancer Genetics and Cytogenetics. 84(1). 24–26. 33 indexed citations
14.
Schmidt, Stephen, et al.. (1987). Beef steer performance on cimarron alfalfa and serala and AU Lotan sericea lespedeza pastures. 5 indexed citations
15.
Hoveland, C. S., Stephen Schmidt, C. C. King, et al.. (1984). Steer performance as affected by fungal endophyte on Kentucky 31 tall fescue pasture. 1 indexed citations
16.
Hoveland, C. S., et al.. (1982). Triumph : a new winter-productive tall fescue variety. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026